The Galien Foundation Gala Celebrates Life Sciences Innovators
NEW YORK — The Galien Foundation, a leading global institution, has recently celebrated the achievements and innovations in life sciences at the Prix Galien USA Forum and the 19th annual Prix Galien Awards Gala. This prestigious event took place at the renowned American Museum of Natural History, honoring outstanding contributors to healthcare advancements.
Among the prominent recognitions was The Roy Vagelos Pro Bono Humanum Award for Global Health Equity, awarded to Michael J. Fox for his significant role in advancing research efforts for Parkinson's disease. Through the establishment of The Michael J. Fox Foundation, he has not only spearheaded crucial research initiatives but also fostered a deeper understanding in the medical community and raised awareness on a global scale. His fervent dedication has provided hope to millions battling the disease, emphasizing the need for continuous medical research.
In his heartfelt acceptance speech, Fox extended gratitude to The Galien Foundation, highlighting the collaborative efforts of scientists present who share a commitment to finding a cure for Parkinson’s disease. He referenced the profound legacy of humanitarian Elie Wiesel and underscored the importance of collective action to improve global health.
Following this, the Prix Galien USA Committees, including an esteemed panel of 25 committee members, recognized the winners of the 2025 Prix Galien Awards across multiple categories. These included distinctions for Best Biotechnology Product, Best Pharmaceutical Product, and Best Digital Health Solution, among others.
"It is an immense honor to acknowledge all the nominees and winners whose pioneering work enhances human health," remarked Kenneth Frazier, Committee Chair and former CEO of Merck & Co. He stressed the importance of innovation in driving forward the healthcare industry, highlighting the dedication shown by each participant in the awards process.
Dr. Michael Rosenblatt, another key figure on the committee, praised the unwavering commitment of nominees and noted that the impact of their work on patient care is both commendable and inspiring. This sentiment echoes through the community committed to bettering healthcare standards and developing groundbreaking technologies.
Notable Award Winners of the 2025 Prix Galien
The awards for 2025 recognized several groundbreaking contributions:
- Best Biotechnology Product: Regeneron and Sanofi for Dupixent
- Best Pharmaceutical Product: Gilead Sciences for PHESGO
- Best Product for Rare/Orphan Diseases: Servier Pharmaceuticals for VORANIGO
- Best Medical Technology: Edwards Lifesciences for the Edwards EVOQUE Transcatheter Tricuspid Valve Replacement System
- Best Digital Health Solution: ?URA for the Oura Ring 4
- Prix Galien EcoHealth: Infinite Cooling
- Best Startup – Biotechnology: Dren Bio
- Best Startup – Medical Technology/Digital Health: Resuscitec GmbH
Bruno Cohen, the Chairman of The Galien Foundation, expressed pride in the awardees, commending their commitment to innovation and emphasizing the critical role they play in advancing medicine and improving patient outcomes.
The Role of the Prix Galien Awards Committee
The Prix Galien Awards Committee encompasses an impressive roster of experts, including renowned figures like Michael Rosenblatt, who leads the Biotechnology, Pharmaceutical, and Rare/Orphan Diseases sectors. Other notable members include Linda Buck, a Nobel Laureate; Sue Desmond-Hellmann, former CEO of the Bill & Melinda Gates Foundation; and many other distinguished professionals dedicated to advancing healthcare.
The diversity of expertise within the committee reflects the multifaceted nature of modern medicine, as well as the collaboration necessary to tackle current healthcare challenges. They aim to foster a community that uplifts and promotes innovation across the life sciences spectrum, recognizing that each achievement contributes to the overall goal of improving health.
About The Galien Foundation
The Galien Foundation plays a pivotal role in recognizing and promoting excellence in scientific innovation aimed at enhancing human health. With a vision of catalyzing the development of cutting-edge treatments and technologies, the Foundation oversees the Prix Galien, an international awards initiative dedicated to advancing medicine across various countries.
This prestigious award, which has its origins dating back to 1970, has come to symbolize a significant milestone in biopharmaceutical research, similar to the Nobel Prize in its impact and recognition. This event showcases the continuous pursuit of excellence in the medical field.
Frequently Asked Questions
1. What is the purpose of the Prix Galien Awards?
The Prix Galien Awards aim to honor innovations and contributions in the life sciences that enhance human health and improve patient care.
2. Who received the top award at the recent ceremony?
Michael J. Fox was honored with The Roy Vagelos Pro Bono Humanum Award for Global Health Equity for his work in Parkinson's disease advocacy.
3. How many categories were there in the 2025 Prix Galien Awards?
The awards recognized winners across multiple categories including Biotechnology, Pharmaceutical Products, and Digital Health Solutions.
4. What is the Galien Foundation's vision?
The Galien Foundation's vision is to be a catalyst for innovative treatments and technologies that impact medical practice and save lives.
5. When was the Prix Galien founded?
The Prix Galien was established in 1970, named in honor of Galien, the father of medical science.
